Venrock Adviser, LLC
NEW YORK, NY · CIK 1615982 · 13F filing filed 2024-11-14
SEC-registered investment adviser since 2014 · limited liability company
- Assets managed$4.5bn
- Staff11 · 11 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds7 (1 hedge) · $4.5bn gross assets
- Form ADV · 2026-04-28SEC adviser record
- Legal entityVENROCK ADVISER, LLC (US)
- Kindhedge funds, private equity
- Others nearbyNew York, NY, Palo Alto, CA
As an employer
- Offices in1 country
- Private fundshedge 1, private equity 6
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 11 |
| Palo Alto, CAUnited States |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$1.9bn
reported value
+21.6% vs Q2 2024
38positions
65.6%in top 10
4 new
5 added
6 reduced
1 sold out
vs Q2 2024
Holdings, Q3 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| APOGEE THERAPEUTICS INC COM | $498.9m26.13% | Unchanged |
| OCULAR THERAPEUTIX INC OCUL | $111.0m5.82% | Unchanged |
| ENLIVEN THERAPEUTICS INC ELVN | $102.8m5.39% | Unchanged |
| VIRIDIAN THERAPEUTICS INC VRDN | $88.3m4.63% | Added +38 |
| APPLIED THERAPEUTICS INC APLT | $83.5m4.37% | Added +282.1k |
| SPYRE THERAPEUTICS INC SYRE | $79.0m4.14% | Unchanged |
| DYNE THERAPEUTICS INC DYN | $78.1m4.09% | Unchanged |
| ORUKA THERAPEUTICS INC ORKA | $75.6m3.96% | New |
| KALVISTA PHARMACEUTICALS INC KALV | $72.4m3.79% | Unchanged |
| PHARVARIS N V PHVS | $62.9m3.29% | Unchanged |
| COGENT BIOSCIENCES INC COGT | $61.4m3.22% | Unchanged |
| DIANTHUS THERAPEUTICS INC DNTH | $47.8m2.50% | Reduced -350.0k |
| 4D MOLECULAR THERAPEUTICS IN FDMT | $47.6m2.49% | Unchanged |
| MERUS N V MRUS | $45.4m2.38% | Reduced -355.3k |
| ORIC PHARMACEUTICALS INC ORIC | $45.0m2.36% | Unchanged |
| ERASCA INC ERAS | $44.3m2.32% | Unchanged |
| PRAXIS PRECISION MEDICINES I PRAX | $40.6m2.13% | Unchanged |
| ASTRIA THERAPEUTICS INC CATB | $38.1m1.99% | Reduced -150.0k |
| TERNS PHARMACEUTICALS INC COM | $28.4m1.49% | Unchanged |
| AQUESTIVE THERAPEUTICS INC AQST | $27.7m1.45% | Unchanged |
| EDGEWISE THERAPEUTICS INC EWTX | $26.7m1.40% | Reduced -818.2k |
| ARTIVA BIOTHERAPEUTICS INC ARTV | $24.9m1.30% | New |
| ENGENE HOLDINGS INC COM | $23.5m1.23% | Added +739.9k |
| CULLINAN THERAPEUTICS INC CGEM | $23.1m1.21% | Unchanged |
| MERSANA THERAPEUTICS INC COM | $21.4m1.12% | Unchanged |
| TAYSHA GENE THERAPIES INC TSHA | $18.1m0.95% | Unchanged |
| ABIVAX SA ABVX | $15.5m0.81% | Unchanged |
| TREVI THERAPEUTICS INC TRVI | $11.4m0.60% | Added +19 |
| ARVINAS INC ARVN | $11.2m0.59% | Reduced -173.3k |
| ADVERUM BIOTECHNOLOGIES INC ADVM | $10.3m0.54% | Unchanged |
| CENTURY THERAPEUTICS INC IPSC | $9.2m0.48% | Unchanged |
| ZURA BIO LTD ZURA | $8.2m0.43% | Reduced -4.0m |
| PERCEPTIVE CAP SOLUTIONS COR FRNM | $7.5m0.39% | Unchanged |
| CABALETTA BIO INC CABA | $7.4m0.39% | Unchanged |
| CASI PHARMACEUTICALS INC CASIF | $6.1m0.32% | Added +875.6k |
| TENAYA THERAPEUTICS INC TNYA | $3.0m0.16% | Unchanged |
| INSTIL BIO INC TIL | $2.2m0.12% | New |
| TENAX THERAPEUTICS INC TENX | $720.8k0.04% | New |
Sold out since Q2 2024
| Security | Value then |
|---|---|
| ARCA BIOPHARMA INC | $3.3m866.4k shares |